Doctors who have treated patients with the disease could soon benefit from medical cannabis, according to a new report from Newsweek.
As more doctors begin to prescribe cannabis, their patients will benefit from better outcomes.
The report, which is based on a survey of more than 1,000 people with chronic T.D.E. who have received T.B.I.D., was written by neuroscientist Dr. Mark Ware and medical ethicist Drs.
Jonathan M. Ouellette and William P. Raskin.
They looked at the outcomes of patients who were treated with medical cannabis in the U.S. and Canada.
They found that more than a third of the people in their survey had improved outcomes with cannabis.
They were more likely to have milder T.A.I., lower overall disability, and a lower risk of death.
These outcomes were better than those of patients receiving no treatment, which did not result in any improvement.
Dr. Ware and Dr. Rachin also point out that cannabis may have the potential to help prevent or treat certain conditions in the future.
These conditions include cancer and other diseases that may require more aggressive treatment, or chronic pain and neurodegenerative diseases.
The researchers say the cannabis could be useful in treating these conditions, as well as a range of other conditions, such as chronic fatigue syndrome, multiple sclerosis, PTSD, depression, post-traumatic stress disorder, epilepsy, multiple myeloma, and many others.
“As we become more comfortable with medical marijuana, the potential benefits of treating the disease with it are enormous,” Dr. Ware said in a statement.
“I hope that this study will help us make that decision.”
According to Ware and Rachins report, the researchers looked at T.I.’s effects on patients, as they are known.
They did not look at patients who are not suffering from T.E., but they did consider patients with PTSD, which could be a factor in their improvement.
The study also looked at patients with multiple sclerosis.
There, the research team found that about 30 percent of the patients treated with the cannabis had improved.
The researchers say they hope their findings will help the American Medical Association (AMA) recognize cannabis as a treatment option for T.T.E.: PTSD, multiple-myeloma and epilepsy.